Creator of “stupid cancer app” works towards addressing long standing issue of how to enhance clinical trials?
Company Gryt recently inked a deal with BMS , where the latter would use former’s mobile app in order to enhance clinical trial design and patient well being.
BMS believes that using this app would give them access to voice of patients, an aspect which is of utmost importance in clinical trials.
It also believes having access to this patient data would help them make informed decisions on trials and redesign protocols wherever necessary.
Gryt’s unique selling point is its real time data and insights that it is able to tap via its remarkable app. Also, since company has nurtured its relationship with participants over a course of time it can revisit each of them for any follow ups.
App has quarter a million download and is available on both Android and app store.
We long to see more such deals where real time and accurate site data could be leveraged by pharmaceutical behemoths to make decisions that drive better healthcare outcomes.